We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Court Keeps Aciphex Free Of Generic Competition

Law360 (May 11, 2007, 12:00 AM EDT) -- A district court ruled Friday that generic drug companies Teva Pharmaceutical Industries Ltd. and Dr. Reddy’s Laboratories Ltd. infringed Eisai Co. Ltd.’s patent on the ulcer medicine Aciphex.

In a 62-page opinion, Judge Gerard E. Lynch of the U.S. District Court in Manhattan said Japanese pharmaceutical company Eisai had not engaged in inequitable conduct.

“Defendants have failed to prove inequitable conduct by clear and convincing evidence, and…plaintiffs accordingly have established their claim of patent infringement,” Judge Lynch wrote.

The U.S. subsidiary of Eisai first sued India-based...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.